Shanghai Bao Pharmaceuticals files HKEX next-day return disclosing share repurchase for cancellation

• Shanghai Bao Pharmaceuticals repurchased 110,900 H shares on July 22 for treasury, no cancellations.
• Buyback executed on HKEX at HKD 17.63–18.39 per share; aggregate consideration HKD 1,995,484.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260722-12252692), on July 22, 2026, and is solely responsible for the information contained therein.